Headline: New York Times, 8/31/2026
Rebecca Robbins reports:
A spokesman for Revolution Medicines, Brian Crawford, said the price of its new drug, Rasonque, “reflects its differentiation and the meaningful benefit it provides for patients.”
As is typical with other cancer drugs, the vast majority of the cost of Rasonque is expected to be covered through insurance, with varying out-of-pocket costs for patients. Mr. Crawford said uninsured and underinsured patients who met certain financial and medical criteria would receive the drug for free. The drug, also known as daraxonrasib [as in 'draconian'?], is taken as two pills a day.
Let's do the math: $663 X 2 = $1,326 x 365 = $483,990.
No comments:
Post a Comment